FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
作者信息
Kahan B D
机构信息
University of Texas Medical School, Houston 77030, USA.
出版信息
Transplant Proc. 1998 Aug;30(5):2210-3. doi: 10.1016/s0041-1345(98)00593-4.
PMID:9723444
Abstract
摘要
相似文献
1
FTY720: a new immunosuppressive agent with novel mechanism(s) of action.FTY720：一种具有新型作用机制的新型免疫抑制剂。
Transplant Proc. 1998 Aug;30(5):2210-3. doi: 10.1016/s0041-1345(98)00593-4.
2
Preclinical evaluation of a new immunosuppressive agent, FTY720.新型免疫抑制剂FTY720的临床前评估
Clin Biochem. 1998 Jul;31(5):369-73. doi: 10.1016/s0009-9120(98)00043-5.
3
FTY720: mechanisms of action and its effect on organ transplantation (review).
Transplant Proc. 1999 Nov;31(7):2779-82. doi: 10.1016/s0041-1345(99)00564-3.
4
FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.FTY720是一种具有促胰岛素分泌活性的新型免疫抑制剂，可延长小鼠胰岛移植模型中的移植物存活时间。
Transplant Proc. 2001 Feb-Mar;33(1-2):672-3. doi: 10.1016/s0041-1345(00)02195-3.
5
FTY 720.FTY 720.
Drugs R D. 1999 Jan;1(1):78-80. doi: 10.2165/00126839-199901010-00026.
6
Prolongation of concordant xenograft survival by treatment with FTY720.使用FTY720治疗可延长协调性异种移植物的存活时间。
Transplant Proc. 1998 Dec;30(8):4163-5. doi: 10.1016/s0041-1345(98)01379-7.
7
FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.新型免疫抑制剂FTY720通过加速淋巴细胞归巢诱导循环淋巴细胞滞留。
Transplant Proc. 1999 Feb-Mar;31(1-2):1230-3. doi: 10.1016/s0041-1345(98)01975-7.
8
A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation.FTY720的短期疗程疗法可延长犬肾移植后的同种异体移植物存活时间。
Transplant Proc. 1999 Nov;31(7):2783-4. doi: 10.1016/s0041-1345(99)00565-5.
9
Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation.
Transplant Proc. 2002 May;34(3):973-4. doi: 10.1016/s0041-1345(02)02722-7.
10
Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.新型免疫抑制剂FTY720在犬肾同种异体移植模型中的剂量依赖性研究。
Transplant Proc. 1999 Feb-Mar;31(1-2):1208-9. doi: 10.1016/s0041-1345(98)01967-8.
引用本文的文献
1
Vesicle Fusion as a Target Process for the Action of Sphingosine and Its Derived Drugs.囊泡融合作为鞘氨醇及其衍生药物作用的靶标过程。
Int J Mol Sci. 2022 Jan 19;23(3):1086. doi: 10.3390/ijms23031086.
2
Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells.多发性硬化症药物 FTY-720 的毒性是由神经内分泌细胞中细胞器的异型融合介导的。
Sci Rep. 2019 Dec 5;9(1):18471. doi: 10.1038/s41598-019-55106-w.
3
Emerging evidence for the modulation of exocytosis by signalling lipids.信号脂质对胞吐作用的调节作用的新证据。
FEBS Lett. 2018 Nov;592(21):3493-3503. doi: 10.1002/1873-3468.13178. Epub 2018 Jul 10.
4
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.FTY720，一种治疗急变期慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的新选择。
J Clin Invest. 2007 Sep;117(9):2408-21. doi: 10.1172/JCI31095.
5
FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.FTY720可延长透明角膜移植片的存活时间，且对不同淋巴细胞群体有不同影响。
Br J Ophthalmol. 2004 Jul;88(7):915-9. doi: 10.1136/bjo.2003.034017.
Zotero 插件